 |
Overview
|
|
QLT Inc. is a pharmaceutical company dedicated to the development and commercialization of innovative therapies for the eye. We are focused on our commercial product Visudyne® for the treatment of wet-AMD, and the development of drugs to be delivered in our proprietary punctal plug devices.
Our vision is to be a leading ocular company bringing innovative therapies to patients and the medical community. The company's strategy is straightforward:
- Maximize the revenue of our commercial product: Visudyne.
- Continue to build a strong ocular pipeline through early-stage development, clinical trials, in-licensing and other expansion opportunities.
- Manage the business for growth.
|
|
|
| |
|
|
|
|
|
|
|
|
